Separation of inhibitory activity from biologically active parathyroid hormone in patients with pseudohypoparathyroidism type I.
Patients with pseudohypoparathyroidism type I have the symptoms of hypoparathyroidism despite elevated levels of immunoreactive parathyroid hormone (PTH). However, the circulating levels of bioactive PTH, as measured in a cytochemical bioassay, are generally within the normal range suggesting that the high levels of immunoreactive PTH are either due to the presence of biologically inactive fragments of parathyroid hormone or to the presence of an 'inhibitor' of PTH bioactivity. Gel-permeation chromatography has been used to fractionate plasma from patients with pseudohypoparathyroidism type I and revealed the presence of high levels of bioactive PTH and of an 'inhibitor'. This inhibitory activity was absent or much lower in plasma from control subjects. These results indicate, therefore, that in pseudohypoparathyroidism type I the expression of the biological activity of PTH at the level of the kidney is affected by the presence of a circulating inhibitor which can be separated from intact PTH by gel-permeation chromatography.
D000293:Adolescent; D000328:Adult; D001681:Biological Assay; D002850:Chromatography, Gel; D005260:Female; D006651:Histocytochemistry; D006801:Humans; D008297:Male; D010281:Parathyroid Hormone / Q000302:isolation & purification*; D010446:Peptide Fragments / Q000302:isolation & purification; D011547:Pseudohypoparathyroidism / Q000097:blood*
D010281:Parathyroid Hormone; D010446:Peptide Fragments